AI-driven, scalable molecular tumor board platform paired with a medical expert group delivering somatic and pharmacogenomics consultations for oncologists, clinical labs, life-sciences organizations, and payers. Accelerates guideline-based genomic insights to clinicians and patients via integrated oncology, oncology pharmacy, molecular pathology, and data-integration expertise.